表紙
市場調查報告書

全球神經性疼痛管理市場分析

Global Market Study on Neuropathic Pain Management: Tricyclic Anti-depressants Drug Class Segment Projected to Witness Highest Growth Through 2026

出版商 Persistence Market Research 商品編碼 674864
出版日期 內容資訊 英文 211 Pages
商品交期: 2-3個工作天內
價格
全球神經性疼痛管理市場分析 Global Market Study on Neuropathic Pain Management: Tricyclic Anti-depressants Drug Class Segment Projected to Witness Highest Growth Through 2026
出版日期: 2018年07月19日內容資訊: 英文 211 Pages
簡介

本報告提供全球神經性疼痛管理市場相關調查,提供市場概要,各藥物級·適應症·流通管道·各地區的市場規模的變化與預測(過去5年·今後8年份),成長要素及阻礙因素分析,市場機會,市場佔有率,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 摘要整理

第2章 簡介

  • 市場區分
  • 市場定義

第3章 全球經濟預測

  • 國內生產總值:各地各國
  • 醫療設備領域預測
  • 醫療保健指標

第4章 市場機會分析

  • 宏觀經濟要素
  • 市場機會分析

第5章 市場著眼點

  • 宏觀經濟要素
  • 市場機會分析
  • 成長要素
    • 供給側面的成長要素
    • 需求方面的成長要素
  • 阻礙因素
  • 市場趨勢

第6章 宏觀經濟的前提條件

第7章 北美的神經性疼痛管理市場

  • 簡介
  • 市場規模的變化與預測:各國(實際成果值·預測值)
    • 美國
    • 加拿大
  • 市場規模的變化與預測:各藥物等級(實際成果值·預測值)
    • 三環抗憂鬱藥物
    • 抗痙攣藥
    • SNRI(血清素-正腎上腺素再回收抑制劑危害藥)
    • 辣椒素奶油
    • 局部麻醉
    • 類鴉片物質
    • 類固醇
    • 其他
  • 市場規模的變化與預測:各適應症(實際成果值·預測值)
    • 糖尿病性神經病變
    • 三叉神經痛
    • 帶狀皰疹後遺症神經痛(PHN)
    • 化療誘發性末梢神經病變
    • 其他
  • 市場規模的變化與預測:各流通管道(實際成果值·預測值)
    • 零售藥局
    • 醫院藥局
    • 線上藥局
  • 市場魅力分析:各市場區隔
  • 主要企業的市場集中度
  • 成長要素及阻礙因素 - 影響力分析

第8章 南美的神經性疼痛管理市場

  • 簡介
  • 市場規模的變化與預測:各國(實際成果值·預測值)
    • 阿根廷
    • 巴西
    • 墨西哥
    • 其他
  • 市場規模的變化與預測:各藥物等級(實際成果值·預測值)
  • 市場規模的變化與預測:各適應症(實際成果值·預測值)
  • 市場規模的變化與預測:各流通管道(實際成果值·預測值)
  • 市場魅力分析:各市場區隔
  • 主要企業的市場集中度
  • 成長要素及阻礙因素 - 影響力分析

第9章 歐洲的神經性疼痛管理市場分析與預測

  • 簡介
  • 市場規模的變化與預測:各國(實際成果值·預測值)
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 市場規模的變化與預測:各藥物等級(實際成果值·預測值)
  • 市場規模的變化與預測:各適應症(實際成果值·預測值)
  • 市場規模的變化與預測:各流通管道(實際成果值·預測值)
  • 市場魅力分析:各市場區隔
  • 主要企業的市場集中度
  • 成長要素及阻礙因素 - 影響力分析

第10章 亞太地區(中國以外)的神經性疼痛管理市場

  • 簡介
  • 市場規模的變化與預測:各國(實際成果值·預測值)
    • 日本
    • 印度
    • 澳洲·紐西蘭
    • 其他
  • 市場規模的變化與預測:各藥物等級(實際成果值·預測值)
  • 市場規模的變化與預測:各適應症(實際成果值·預測值)
  • 市場規模的變化與預測:各流通管道(實際成果值·預測值)
  • 市場魅力分析:各市場區隔
  • 主要企業的市場集中度
  • 成長要素及阻礙因素 - 影響力分析

第11章 中東·非洲的神經性疼痛管理市場

  • 簡介
  • 市場規模的變化與預測:各國(實際成果值·預測值)
    • 波灣合作理事會(GCC)
    • 南非
    • 其他
  • 市場規模的變化與預測:各藥物等級(實際成果值·預測值)
  • 市場規模的變化與預測:各適應症(實際成果值·預測值)
  • 市場規模的變化與預測:各流通管道(實際成果值·預測值)
  • 市場魅力分析:各市場區隔
  • 主要企業的市場集中度
  • 成長要素及阻礙因素 - 影響力分析

第12章 預測要素:相關性和影響力

第13章 預測的前提條件

第14章 競爭分析

  • 市場結構:企業各層級
  • 競爭情形
  • 競爭基準
  • 企業簡介
    • Pfizer Inc.
    • Johnson & Johnson Services, Inc
    • Sanofi S.A.
    • GlaxoSmithKline plc.
    • Eli Lilly and Company
    • Bristol-Myers Squibb
    • Biogen Idec, Inc.
    • Baxter Healthcare Corporation
    • Depomed, Inc.

第15章 神經性疼痛管理的全球市場:各地區

  • 簡介/主要的觀察
  • 市場規模的變化與預測:各地區
  • 市場魅力分析:各地區

第16章 全球神經性疼痛管理市場:醫藥品各級

第17章 全球神經性疼痛管理市場:各適應症

第18章 全球神經性疼痛管理市場:各流通管道

第19章 全球神經性疼痛管理市場:分析與預測

  • 市場規模分析:各市場區隔
  • 與前一年同期比較成長率分析:各市場區隔

第20章 調查方法

目錄

This Persistence Market Research (PMR) report examines the 'Global Neuropathic Pain Management Market' for the period 2018-2026. The primary objective of the report is to offer updates and information related to market opportunities in the global neuropathic pain management market.

The Neuropathic Pain Management Market is Segmented as Follows:

  • Neuropathic Pain Management Market, by Drug Class
  • Neuropathic Pain Management Market, by Indication
  • Neuropathic Pain Management Market, by Distribution Channel
  • Neuropathic Pain Management Market, by Region

This report covers the global neuropathic pain management market performance in terms of revenue contribution from various segments. The report begins with an overview of the neuropathic pain management and its definitions. The market viewpoints section underlines macro-economic factors influencing the growth of the neuropathic pain management market along with detailing its opportunity analysis.

The global neuropathic pain management market is segmented based on drug class, indication, distribution channel and region. On the basis of drug class, the market has been segmented as tricyclic anti-depressants anticonvulsants, serotonin-norepinephrine reuptake inhibitor, capsaicin cream, local anaesthesia, opioids, steroids and others.

On the basis of indication, the market is segmented as diabetic neuropathy, trigeminal neuralgia, post-herpetic neuralgia, chemotherapy-induced peripheral neuropathy and others.

On the basis of distribution channel, the market is segmented as hospital pharmacies, retail pharmacies and online pharmacies.

A detailed analysis has been provided for each region in terms of market size, BPS analysis, Y-o-Y growth rate, absolute $ opportunity, and market attractive index. The regional market dynamics provide the key growth driver, restraints, and trends pertaining to each region. The forecast of the neuropathic pain management market by country, drug class, indication, distribution channel are represented in the tabular form for each region. This section also helps to understand the opportunity of the neuropathic pain management market in major countries by each segment.

In the next section of the report, the 'Competitive Landscape' is included to provide report audiences with a dashboard view and to access the key differentiators among the competitor firms. This section is primarily designed to provide clients with an objective and detailed comparative assessment of product offerings and strategies of key providers specific to the market segments. Detailed profiles of players in the neuropathic pain management market are also provided in the report, which highlights company description, product/segment overview, SWOT analysis, financial information, key developments related to market and strategic overview.

The next section of the report highlights the market outlook for 2018-2026 and sets the forecast within the context of the neuropathic pain management market by region. The key regions assessed in this report include North America, Latin America, Europe, Asia Pacific and MEA. A detailed analysis has been provided for each region in terms of market size, Y-o-Y growth rate, absolute $ opportunity, and market attractive index.

The above sections - by drug class, indication, distribution channel - evaluate the historic market analysis for the period of 2013-2017 and growth prospects of the neuropathic pain management market for the period 2018-2026. We have considered 2016 as the base year and provided data for the forecast period.

The final section of report represents the global scenario for the neuropathic pain management market along with Y-o-Y growth and market forecast till 2026. This section also evaluates the global market opportunity over the forecast period and also the absolute dollar opportunity for each year. This section will help to understand the overall market growth of the neuropathic pain management market and the opportunity analysis for each year over the forecast period.

Bottom-up approach is used to validate the total market size obtained. The forecast presented in the report provides total revenue of the neuropathic pain management market over 2018-2026. While forecasting the market size, we have considered the impact of several factors such product approvals for neuropathic pain management, R&D investment by major players, pipeline analysis, penetration of products in different distribution channel, generic penetration across all regions, etc. However, quantifying the market across the aforementioned segments and regions is more a matter of quantifying expectations and identifying opportunities rather than rationalizing them after the forecast has been completed. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global market.

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy
  • 2.3. Inclusion and Exclusion

3. Global Economic Outlook

  • 3.1. Gross Domestic Product by Region & Country, 2006 - 2021
  • 3.2. Medical Devices Sector Outlook
  • 3.3. Healthcare Indicators

4. Neuropathic Pain Management Market Opportunity Analysis

  • 4.1. Macro-Economic Factors
  • 4.2. Opportunity Analysis

5. Market View Point

  • 5.1. Macro-Economic Factors
  • 5.2. Opportunity Analysis
  • 5.3. Drivers
    • 5.3.1. Supply Side Drivers
    • 5.3.2. Demand Side Drivers
  • 5.4. Restraints
  • 5.5. Trends

6. Macroeconomic Assumptions

7. North America Neuropathic Pain Management Market Analysis 2013-2017 and Forecast 2018-2026

  • 7.1. Introduction
  • 7.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013-2017
    • 7.2.1. U.S.
    • 7.2.2. Canada
  • 7.3. Market Size (US$ Mn) Forecast By Country, 2018-2026
  • 7.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Class 2013-2017
    • 7.4.1. Tricyclic Anti-Depressants
    • 7.4.2. Anticonvulsants
    • 7.4.3. SNRI's
    • 7.4.4. Capsaicin Cream
    • 7.4.5. Local Anesthesia
    • 7.4.6. Opioids
    • 7.4.7. Steroids
    • 7.4.8. Others
  • 7.5. Market Size (US$ Mn) Forecast By Drug Class 2018-2026
  • 7.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2017
    • 7.6.1. Diabetic Neuropathy
    • 7.6.2. Trigeminal Neuralgia
    • 7.6.3. Post-Herpetic Neuralgia
    • 7.6.4. Chemotherapy-Induced Peripheral Neuropathy
    • 7.6.5. Others
  • 7.7. Market Size (US$ Mn) Forecast By Indication, 2018-2026
  • 7.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
    • 7.8.1. Retail Pharmacies
    • 7.8.2. Hospital Pharmacies
    • 7.8.3. Online Pharmacies
  • 7.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 7.10. Market Attractiveness Analysis
    • 7.10.1. By Country
    • 7.10.2. By Drug Class
    • 7.10.3. By Indication
    • 7.10.4. By Distribution Channel
  • 7.11. Key Market Participants - Intensity Mapping
  • 7.12. Drivers and Restraints - Impact Analysis

8. Latin America Neuropathic Pain Management Market Analysis 2013-2017 and Forecast 2018-2026

  • 8.1. Introduction
  • 8.2. Regional Market Trends
  • 8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013-2017
    • 8.3.1. Argentina
    • 8.3.2. Brazil
    • 8.3.3. Mexico
    • 8.3.4. Rest of Latin America
  • 8.4. Market Size (US$ Mn) Forecast By Country, 2018-2026
  • 8.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Class 2013-2017
    • 8.5.1. Tricyclic Anti-Depressants
    • 8.5.2. Anticonvulsants
    • 8.5.3. SNRI's
    • 8.5.4. Capsaicin Cream
    • 8.5.5. Local Anesthesia
    • 8.5.6. Opioids
    • 8.5.7. Steroids
    • 8.5.8. Others
  • 8.6. Market Size (US$ Mn) Forecast By Drug Class 2018-2026
  • 8.7. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2017
    • 8.7.1. Diabetic Neuropathy
    • 8.7.2. Trigeminal Neuralgia
    • 8.7.3. Post-Herpetic Neuralgia
    • 8.7.4. Chemotherapy-Induced Peripheral Neuropathy
    • 8.7.5. Others
  • 8.8. Market Size (US$ Mn) Forecast By Indication, 2018-2026
  • 8.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
    • 8.9.1. Retail Pharmacies
    • 8.9.2. Hospital Pharmacies
    • 8.9.3. Online Pharmacies
  • 8.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 8.11. Market Attractiveness Analysis
    • 8.11.1. By Country
    • 8.11.2. By Drug Class
    • 8.11.3. By Indication
    • 8.11.4. By Distribution Channel
  • 8.12. Key Market Participants - Intensity Mapping
  • 8.13. Drivers and Restraints - Impact Analysis

9. Europe Neuropathic Pain Management Market Analysis 2013-2017 and Forecast 2018-2026

Market forecast and analysis in Germany, U.K., France, Italy, Spain, Russia and rest of Europe

  • 9.1. Introduction
  • 9.2. Regional Market Trends
  • 9.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013-2017
    • 9.3.1. Germany
    • 9.3.2. U.K.
    • 9.3.3. France
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Russia
    • 9.3.7. Rest of Europe
  • 9.4. Market Size (US$ Mn) Forecast By Country, 2018-2026
  • 9.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Class 2013-2017
    • 9.5.1. Tricyclic Anti-Depressants
    • 9.5.2. Anticonvulsants
    • 9.5.3. SNRI's
    • 9.5.4. Capsaicin Cream
    • 9.5.5. Local Anesthesia
    • 9.5.6. Opioids
    • 9.5.7. Steroids
    • 9.5.8. Others
  • 9.6. Market Size (US$ Mn) Forecast By Drug Class 2018-2026
  • 9.7. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2017
    • 9.7.1. Diabetic Neuropathy
    • 9.7.2. Trigeminal Neuralgia
    • 9.7.3. Post-Herpetic Neuralgia
    • 9.7.4. Chemotherapy-Induced Peripheral Neuropathy
    • 9.7.5. Others
  • 9.8. Market Size (US$ Mn) Forecast By Indication, 2018-2026
  • 9.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
    • 9.9.1. Retail Pharmacies
    • 9.9.2. Hospital Pharmacies
    • 9.9.3. Online Pharmacies
  • 9.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 9.11. Market Attractiveness Analysis
    • 9.11.1. By Country
    • 9.11.2. By Drug Class
    • 9.11.3. By Indication
    • 9.11.4. By Distribution Channel
  • 9.12. Key Market Participants - Intensity Mapping
  • 9.13. Drivers and Restraints - Impact Analysis

10. Asia-Pacific Excluding China Neuropathic Pain Management Market Analysis 2013-2017 and Forecast 2018-2026

  • 10.1. Introduction
  • 10.2. Regional Market Trends
  • 10.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013-2017
    • 10.3.1. Japan
    • 10.3.2. India
    • 10.3.3. Australia and New Zealand
    • 10.3.4. Rest of Asia Pacific
  • 10.4. Market Size (US$ Mn) Forecast By Country, 2018-2026
  • 10.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Class 2013-2017
    • 10.5.1. Tricyclic Anti-Depressants
    • 10.5.2. Anticonvulsants
    • 10.5.3. SNRI's
    • 10.5.4. Capsaicin Cream
    • 10.5.5. Local Anesthesia
    • 10.5.6. Opioids
    • 10.5.7. Steroids
    • 10.5.8. Others
  • 10.6. Market Size (US$ Mn) Forecast By Drug Class 2018-2026
  • 10.7. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2017
    • 10.7.1. Diabetic Neuropathy
    • 10.7.2. Trigeminal Neuralgia
    • 10.7.3. Post-Herpetic Neuralgia
    • 10.7.4. Chemotherapy-Induced Peripheral Neuropathy
    • 10.7.5. Others
  • 10.8. Market Size (US$ Mn) Forecast By Indication, 2018-2026
  • 10.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
    • 10.9.1. Retail Pharmacies
    • 10.9.2. Hospital Pharmacies
    • 10.9.3. Online Pharmacies
  • 10.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 10.11. Market Attractiveness Analysis
    • 10.11.1. By Country
    • 10.11.2. By Drug Class
    • 10.11.3. By Indication
    • 10.11.4. By Distribution Channel
  • 10.12. Key Market Participants - Intensity Mapping
  • 10.13. Drivers and Restraints - Impact Analysis

11. Middle East & Africa Neuropathic Pain Management Market Analysis 2013-2017 and Forecast 2018-2026

Market forecast and analysis in GCC Countries, South Africa, and rest of MEA

  • 11.1. Introduction
  • 11.2. Key Regulations
  • 11.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013-2017
    • 11.3.1. GCC Countries
    • 11.3.2. South Africa
    • 11.3.3. Rest of MEA
  • 11.4. Market Size (US$ Mn) Forecast By Country, 2018-2026
  • 11.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Class 2013-2017
    • 11.5.1. Tricyclic Anti-Depressants
    • 11.5.2. Anticonvulsants
    • 11.5.3. SNRI's
    • 11.5.4. Capsaicin Cream
    • 11.5.5. Local Anesthesia
    • 11.5.6. Opioids
    • 11.5.7. Steroids
    • 11.5.8. Others
  • 11.6. Market Size (US$ Mn) Forecast By Drug Class 2018-2026
  • 11.7. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2017
    • 11.7.1. Diabetic Neuropathy
    • 11.7.2. Trigeminal Neuralgia
    • 11.7.3. Post-Herpetic Neuralgia
    • 11.7.4. Chemotherapy-Induced Peripheral Neuropathy
    • 11.7.5. Others
  • 11.8. Market Size (US$ Mn) Forecast By Indication, 2018-2026
  • 11.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
    • 11.9.1. Retail Pharmacies
    • 11.9.2. Hospital Pharmacies
    • 11.9.3. Online Pharmacies
  • 11.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Country
    • 11.11.2. By Drug Class
    • 11.11.3. By Indication
    • 11.11.4. By Distribution Channel
  • 11.12. Key Market Participants - Intensity Mapping
  • 11.13. Drivers and Restraints - Impact Analysis

12. Forecast Factors: Relevance and Impact

13. Forecast Assumptions

14. Competition Analysis

  • 14.1. Market Structure by Tier of Companies
  • 14.2. Competition Dashboard
  • 14.3. Competition Benchmarking
  • 14.4. Company Deep Dive
    • 14.4.1. Pfizer Inc.
      • 14.4.1.1. Overview
      • 14.4.1.2. Product and Technology Portfolio
      • 14.4.1.3. Production Footprint
      • 14.4.1.4. Sales Footprint
      • 14.4.1.5. Channel Footprint
      • 14.4.1.6. Strategy
        • 14.4.1.6.1. Marketing Strategy
        • 14.4.1.6.2. Product Strategy
        • 14.4.1.6.3. Channel Strategy
    • 14.4.2. Johnson & Johnson Services, Inc
      • 14.4.2.1. Overview
      • 14.4.2.2. Product and Technology Portfolio
      • 14.4.2.3. Production Footprint
      • 14.4.2.4. Sales Footprint
      • 14.4.2.5. Channel Footprint
      • 14.4.2.6. Strategy
        • 14.4.2.6.1. Marketing Strategy
        • 14.4.2.6.2. Product Strategy
        • 14.4.2.6.3. Channel Strategy
    • 14.4.3. Sanofi S.A.
      • 14.4.3.1. Overview
      • 14.4.3.2. Product and Technology Portfolio
      • 14.4.3.3. Production Footprint
      • 14.4.3.4. Sales Footprint
      • 14.4.3.5. Channel Footprint
      • 14.4.3.6. Strategy
        • 14.4.3.6.1. Marketing Strategy
        • 14.4.3.6.2. Product Strategy
        • 14.4.3.6.3. Channel Strategy
    • 14.4.4. GlaxoSmithKline plc.
      • 14.4.4.1. Overview
      • 14.4.4.2. Product and Technology Portfolio
      • 14.4.4.3. Production Footprint
      • 14.4.4.4. Sales Footprint
      • 14.4.4.5. Channel Footprint
      • 14.4.4.6. Strategy
        • 14.4.4.6.1. Marketing Strategy
        • 14.4.4.6.2. Product Strategy
        • 14.4.4.6.3. Channel Strategy
    • 14.4.5. Eli Lilly and Company
      • 14.4.5.1. Overview
      • 14.4.5.2. Product and Technology Portfolio
      • 14.4.5.3. Production Footprint
      • 14.4.5.4. Sales Footprint
      • 14.4.5.5. Channel Footprint
      • 14.4.5.6. Strategy
        • 14.4.5.6.1. Marketing Strategy
        • 14.4.5.6.2. Product Strategy
        • 14.4.5.6.3. Channel Strategy
    • 14.4.6. Bristol-Myers Squibb
      • 14.4.6.1. Overview
      • 14.4.6.2. Product and Technology Portfolio
      • 14.4.6.3. Production Footprint
      • 14.4.6.4. Sales Footprint
      • 14.4.6.5. Channel Footprint
      • 14.4.6.6. Strategy
        • 14.4.6.6.1. Marketing Strategy
        • 14.4.6.6.2. Product Strategy
        • 14.4.6.6.3. Channel Strategy
    • 14.4.7. Biogen Idec, Inc.
      • 14.4.7.1. Overview
      • 14.4.7.2. Product and Technology Portfolio
      • 14.4.7.3. Production Footprint
      • 14.4.7.4. Sales Footprint
      • 14.4.7.5. Channel Footprint
      • 14.4.7.6. Strategy
        • 14.4.7.6.1. Marketing Strategy
        • 14.4.7.6.2. Product Strategy
        • 14.4.7.6.3. Channel Strategy
    • 14.4.8. Baxter Healthcare Corporation
      • 14.4.8.1. Overview
      • 14.4.8.2. Product and Technology Portfolio
      • 14.4.8.3. Production Footprint
      • 14.4.8.4. Sales Footprint
      • 14.4.8.5. Channel Footprint
      • 14.4.8.6. Strategy
        • 14.4.8.6.1. Marketing Strategy
        • 14.4.8.6.2. Product Strategy
        • 14.4.8.6.3. Channel Strategy
    • 14.4.9. Depomed, Inc.
      • 14.4.9.1. Overview
      • 14.4.9.2. Product and Technology Portfolio
      • 14.4.9.3. Production Footprint
      • 14.4.9.4. Sales Footprint
      • 14.4.9.5. Channel Footprint
      • 14.4.9.6. Strategy
        • 14.4.9.6.1. Marketing Strategy
        • 14.4.9.6.2. Product Strategy
        • 14.4.9.6.3. Channel Strategy

15. Global Neuropathic Pain Management Market Analysis 2013-2017 and Forecast 2018-2026, By Region

  • 15.1. Introduction/Key Findings
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2013-2017
  • 15.3. Market Size (US$ Mn) Forecast By Region, 2018-2026
    • 15.3.1. North America
    • 15.3.2. Latin America
    • 15.3.3. Europe
    • 15.3.4. Asia-Pacific
    • 15.3.5. Middle East & Africa
  • 15.4. Market Attractiveness Analysis By Region

16. Global Neuropathic Pain Management Market Analysis 2013-2017 and Forecast 2018-2026, By Drug Class

  • 16.1. Introduction/Key Findings
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Drug Class 2013-2017
    • 16.2.1. Tricyclic Anti-Depressants
    • 16.2.2. Anticonvulsants
    • 16.2.3. SNRI's
    • 16.2.4. Capsaicin Cream
    • 16.2.5. Local Anesthesia
    • 16.2.6. Opioids
    • 16.2.7. Steroids
    • 16.2.8. Others
  • 16.3. Market Size (US$ Mn) Forecast By Drug Class 2018-2026
  • 16.4. Market Attractiveness Analysis By Drug Class

17. Global Neuropathic Pain Management Market Analysis 2013-2017 and Forecast 2018-2026, By Indication

  • 17.1. Introduction/Key Findings
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2017
    • 17.2.1. Diabetic Neuropathy
    • 17.2.2. Trigeminal Neuralgia
    • 17.2.3. Post-Herpetic Neuralgia
    • 17.2.4. Chemotherapy-Induced Peripheral Neuropathy
    • 17.2.5. Others
  • 17.3. Market Size (US$ Mn) Forecast By Indication, 2018-2026
  • 17.4. Market Attractiveness Analysis By Indication

18. Global Neuropathic Pain Management Market Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel

  • 18.1. Introduction/Key Findings
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
    • 18.2.1. Retail Pharmacies
    • 18.2.2. Hospital Pharmacies
    • 18.2.3. Online Pharmacies
  • 18.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 18.4. Market Attractiveness Analysis By Distribution Channel

19. Global Neuropathic Pain Management Market Analysis 2013-2017 and Forecast 2018-2026

  • 19.1. Market Value Share Analysis By All Segment
  • 19.2. Y-o-Y Growth Analysis By All Segment
  • 19.3. Absolute $ Opportunity

20. Research Methodology

List of Tables

  • Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021 (1/2)
  • Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021 (2/2)
  • Table 03: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 04: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
  • Table 05: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication
  • Table 06: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
  • Table 07: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 08: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
  • Table 09: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication
  • Table 10: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
  • Table 11: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 12: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
  • Table 13: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication
  • Table 14: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
  • Table 15: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 16: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
  • Table 17: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication
  • Table 18: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
  • Table 19: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 20: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
  • Table 21: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication
  • Table 22: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
  • Table 23: Global Neuropathic Pain Management Size (US$ Mn) 2012-2016 and Forecast 2018-2026 By Region,
  • Table 24: Global Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
  • Table 25: Global Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication
  • Table 26: Global Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel

List of Figures

  • Figure 01: Global Neuropathic Pain Management Market Value Share By Drug Class (2018 E)
  • Figure 02: Global Neuropathic Pain Management Market Value Share By Indication (2018 E)
  • Figure 03: Global Neuropathic Pain Management Market Value Share By Distribution Channel (2018 E)
  • Figure 05: Global Neuropathic Pain Management Market Value Share By Region (2018 E)
  • Figure 06: North America Neuropathic Pain Management Market Value Share By Drug Class (2018 E)
  • Figure 07: North America Neuropathic Pain Management Market Value Share By Indication (2018 E)
  • Figure 08: North America Neuropathic Pain Management Market Value Share By Distribution Channel (2018 E)
  • Figure 09: North America Neuropathic Pain Management Market Value Share By Country (2018 E)
  • Figure 10: North America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 11: North America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 12: U.S. Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 13: U.S. Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 14: Canada Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 15: Canada Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 16: North America Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2018-2026
  • Figure 17: North America Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2018-2026
  • Figure 18: North America Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2018-2026
  • Figure 19: North America Neuropathic Pain Management Market Attractiveness Analysis By Country, 2018-2026
  • Figure 20: Latin America Neuropathic Pain Management Market Value Share By Drug Class (2018 E)
  • Figure 21: Latin America Neuropathic Pain Management Market Value Share By Indication (2018 E)
  • Figure 22: Latin America Neuropathic Pain Management Market Value Share By Distribution Channel (2018 E)
  • Figure 23: Latin America Neuropathic Pain Management Market Value Share By Country (2018 E)
  • Figure 24: Latin America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 25: Latin America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 26: Brazil Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 27: Brazil Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 28: Mexico Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 29: Mexico Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 30: Argentina Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 31: Argentina Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 32: Rest of Latin America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 33: Rest of Latin America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 34: Latin America Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2018-2026
  • Figure 35: Latin America Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2018-2026
  • Figure 36: Latin America Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2018-2026
  • Figure 37: Latin America Neuropathic Pain Management Market Attractiveness Analysis By Country, 2018-2026
  • Figure 38: Europe Neuropathic Pain Management Market Value Share By Drug Class (2018 E)
  • Figure 39: Europe Neuropathic Pain Management Market Value Share By Indication (2018 E)
  • Figure 40: Europe Neuropathic Pain Management Market Value Share By Distribution Channel (2018 E)
  • Figure 41: Europe Neuropathic Pain Management Market Value Share By Country (2018 E)
  • Figure 42: Europe Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 43: Europe Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 44: U.K. Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 45: U.K. Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 46: Germany Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-201754
  • Figure 47: Germany Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 48: France Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 49: France Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 50: Italy Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 51: Italy Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 52: Spain Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 53: Spain Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 54: Russia Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 55: Russia Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 56: Rest of Europe Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 57: Rest of Europe Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 58: Europe Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2018-2026
  • Figure 59: Europe Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2018-2026
  • Figure 60: Europe Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2018-2026
  • Figure 61: Europe Neuropathic Pain Management Market Attractiveness Analysis By Country, 2018-2026
  • Figure 62: Asia-Pacific Neuropathic Pain Management Market Value Share By Drug Class (2018 E)
  • Figure 63: Asia-Pacific Neuropathic Pain Management Market Value Share By Indication (2018 E)
  • Figure 64: Asia-Pacific Neuropathic Pain Management Market Value Share By Distribution Channel (2018 E)
  • Figure 65: Asia-Pacific Neuropathic Pain Management Market Value Share By Country (2018 E)
  • Figure 66: Asia-Pacific Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 67: Asia-Pacific Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 68: Japan Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 69: Japan Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 70: China Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 71: China Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 72: India Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 73: India Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 74: Australia and New Zealand Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 75: Australia and New Zealand Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 76: ASEAN Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 77: ASEAN Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 78: Rest of Asia-Pacific Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 79: Rest of Asia-Pacific Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 80: Asia-Pacific Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2018-2026
  • Figure 81: Asia-Pacific Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2018-2026
  • Figure 82: Asia-Pacific Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2018-2026
  • Figure 83: Asia-Pacific Neuropathic Pain Management Market Attractiveness Analysis By Country, 2018-2026
  • Figure 84: MEA Neuropathic Pain Management Market Value Share By Drug Class (2018 E)
  • Figure 85: MEA Neuropathic Pain Management Market Value Share By Indication (2018 E)
  • Figure 86: MEA Neuropathic Pain Management Market Value Share By Distribution Channel (2018 E)
  • Figure 87: MEA Neuropathic Pain Management Market Value Share By Country (2018 E)
  • Figure 88: MEA Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 89: MEA Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 90: South Africa Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 91: South Africa Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 92: GCC Countries Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 93: GCC Countries Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 94: Rest of MEA Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
  • Figure 95: Rest of MEA Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 96: MEA Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2018-2026
  • Figure 97: MEA Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2018-2026
  • Figure 98: MEA Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2018-2026
  • Figure 99: MEA Neuropathic Pain Management Market Attractiveness Analysis By Country, 2018-2026
  • Figure 100: Global Neuropathic Pain Management Market Share Analysis (%), By Region, 2018 & 2026
  • Figure 101: Global Neuropathic Pain Management Market Y-o-Y Analysis (%), By Region, 2018-2026
  • Figure 102: Global Neuropathic Pain Management Market Attractiveness Analysis By Region, 2018-2026
  • Figure 103: Global Neuropathic Pain Management Market Share Analysis (%), By Drug Class, 2018 & 2026
  • Figure 104: Global Neuropathic Pain Management Market Y-o-Y Analysis (%), By Drug Class, 2018-2026
  • Figure 105: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Tricyclic Anti Depressants, 2013-2017
  • Figure 106: Global Tricyclic Neuropathic Pain Management Market Value Analysis (US$ Mn), By Tricyclic Anti Depressants, 2018-2026
  • Figure 107: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Anticonvulsants, 2013-2017
  • Figure 108: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Anticonvulsants, 2018-2026
  • Figure 109: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By SNRI's, 2013-2017
  • Figure 110: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By SNRI's, 2018-2026
  • Figure 111: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Capsaicin Cream, 2013-2017
  • Figure 112: Global Capsaicin Cream Neuropathic Pain Management Market Value Analysis (US$ Mn), By Capsaicin Cream, 2018-2026
  • Figure 113: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Local Anesthesia 2013-2017
  • Figure 114: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Local Anesthesia , 2018-2026
  • Figure 115: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Opioids 2013-2017
  • Figure 116: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Opioids, 2018-2026
  • Figure 117: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Steroids , 2013-2017
  • Figure 118: Global Neuropathic Pain Management Market Value Analysis (US$ Mn),By Steroids, 2018-2026
  • Figure 119: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), by Others, 2013-2017
  • Figure 120: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Others, 2018-2026
  • Figure 121: Global Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2018-2026
  • Figure 122: Global Neuropathic Pain Management Market Share Analysis (%), By Indication , 2018 & 2026
  • Figure 123: Global Neuropathic Pain Management Market Y-o-Y Analysis (%), By Indication , 2018-2026
  • Figure 124: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Diabetic Neuropathy, 2013-2017
  • Figure 125: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Diabetic Neuropathy, 2018-2026
  • Figure 126: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Trigeminal Neuralgia, 2013-2017
  • Figure 127: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Trigeminal Neuralgia, 2018-2026
  • Figure 128: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Post-Herpetic Neuralgia, 2013-2017
  • Figure 129: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Post-Herpetic Neuralgia, 2018-2026
  • Figure 130: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By CIPN, 2013-2017
  • Figure 131: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By CIPN, 2018-2026
  • Figure 132: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Post-Herpetic Neuralgia, 2013-2017
  • Figure 133: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Post-Herpetic Neuralgia, 2018-2026
  • Figure 134: Global Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2018-2026
  • Figure 135: Global Neuropathic Pain Management Market Share Analysis (%), By Distribution Channel, 2018 & 2026
  • Figure 136: Global Neuropathic Pain Management Market Y-o-Y Analysis (%), By Distribution Channel, 2018-2026
  • Figure 137: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Retail Pharmacies, 2013-2017
  • Figure 138: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Retail Pharmacies, 2018-2026
  • Figure 139: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Hospital Pharmacies, 2013-2017
  • Figure 140: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Hospital Pharmacies, 2018-2026
  • Figure 141: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Online Pharmacies, 2013-2017
  • Figure 142: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Online Pharmacies, 2018-2026
  • Figure 143: Global Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2018-2026
  • Figure 144: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), 2012-2016
  • Figure 145: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
  • Figure 146: Global Neuropathic Pain Management Market Absolute $ Opportunity, 2018 - 2026